Regulation Brief October 28, 2026, 8:01 AM ET

Sales of Leqembi total 32.2 billion yen in third quarter 2026

BioArctic AB reported preliminary global revenue for Leqembi of JPY 32.2 billion in the third quarter 2026, generating a royalty of SEK 203.8 million, up about 74 percent from the same period in 2025. The company disclosed the figures under the EU Market Abuse Regulation on October 28 2026.

Primary source

Company press release (PR Newswire), October 28, 2026

Sales of Leqembi® totaled 32.2 billion yen in the third quarter 2026

Read the source: Sales of Leqembi® totaled 32.2 billion yen in the third quarter 2026 prnewswire.com

By The Priority Review desk. Machine-summarized from the source above; not independently reported. How we use automation